SelectQuote | SLQT | Long at $2.18SelectQuote NYSE:SLQT is currently resting within my historical simple moving average zone. This often signals consolidation and a future move (in this case, let's hope up). Looking at the company's financials, NYSE:SLQT is currently profitable. For Q3 2025 (ended March 31, 2025), the company reported a net income of $26.0 million, up from $8.6 million in Q3 2024. This follows a strong Q2 2025 with a net income of $53.2 million. While like most companies there are likely headwinds in 2025 (earnings are projected at a loss of -$0.20 per share due to seasonal fluctuations and investments in 2025 (e.g., new Kansas facility)), profitability is likely to stabilize in 2026, with EPS forecasts of $0.05, supported by improved Medicare reimbursement rates and operational efficiencies. Ongoing Department of Justice allegations could pose risks... but SelectQuote’s recent $350M investment and cost management suggest profitability may continue if legal issues are resolved favorably.
Thus, at $2.18, NYSE:SLQT is in a personal buy zone. There is a potential for the price to dip to the bottom of the historical simple moving average channel (near $1.25) in the near-term, but time will tell.
Targets:
$2.64
$4.24
